Sometimes required in a package insert for a FDA approved drug. Per CFR 21 (2017), major limitations to drug use must be briefly noted. Example would be lack of an effect of the drug in a particular subset of a larger population.
« Back to Glossary IndexContact Us
Recent Posts
Common Topics
analysis
analyze
API
assessment
Camtasia
compliance
connection
continuous learning
Conversation
Data Visualization
eLearning
evaluation
exam
expertise
FDA
guidance
heuristic
knowledge
learning
learning theory
linking
LMS
management
MCQ
Medical Affairs
memory
MSL
multiple-choice
onboarding
online
operations
PowerPoint
presentation
prior knowledge
psychometrics
question
quiz
recall
relationship
technology
test
training
vendor
video
virtual